Open Access

Is the use of preoperative breast MRI predictive of mastectomy?

  • Brigid K. Killelea1, 3Email author,
  • Baiba J. Grube1,
  • Muhammad Rishi1,
  • Liane Philpotts2, 3,
  • Eliza-Jasmine Tran1 and
  • Donald R. Lannin1, 3
World Journal of Surgical Oncology201311:154

https://doi.org/10.1186/1477-7819-11-154

Received: 20 December 2012

Accepted: 30 June 2013

Published: 12 July 2013

Abstract

Background

Several recent studies have described increasing rates of unilateral and bilateral mastectomy among women with newly diagnosed breast cancer. The use of breast magnetic resonance imaging (MRI) has also risen rapidly, leading to speculation that the high false-positive rate and need for multiple biopsies associated with MRI may contribute to more mastectomies. The objective of this study was to determine whether newly diagnosed patients who underwent preoperative MRI were more likely to undergo mastectomy compared with those who did not have a preoperative MRI.

Methods

A retrospective review was performed of all newly diagnosed patients with breast cancer at our academic breast center from 2004 to 2009.

Results

The proportion of newly diagnosed patients with breast cancer having MRI prior to surgery increased from 6% in 2004 to 73% in 2009. Of 628 patients who underwent diagnostic MRI, 369 (59%) had abnormal results, 257 (41%) had one or more biopsies, and 73 had additional sites of cancer diagnosed. Patients with a malignant biopsy, or those with an abnormal MRI who did not undergo biopsy, had an increased mastectomy rate (P<0.01). However, patients with a normal MRI or a benign biopsy actually had a decreased mastectomy rate (P<0.05). Although there was a trend toward more bilateral mastectomies, the overall mastectomy rate did not change over this time period.

Conclusions

Although there is a strong relationship between the result of an MRI and the choice of surgery, the overall effect is not always to increase the mastectomy rate. Some patients who were initially considering mastectomy chose lumpectomy after an MRI.

Background

Carefully conducted randomized controlled trials have shown no significant difference in either overall survival or local recurrence for women who undergo mastectomy versus those who elect to have breast conservation surgery (BCT) followed by radiation therapy for the treatment of early-stage breast cancer [1]. Based on these findings, mastectomy rates had been declining over the past 3 decades in favor of BCT [2], but within the past several years both unilateral and bilateral mastectomy rates have begun to rise [3, 4]. Several reasons for this observed increase have been proposed, including expanded screening for carriers of BRCA1 and BRCA2 genetic mutations, advances in post-mastectomy breast reconstruction, increased public awareness and heightened patient anxiety, and the more liberal use of preoperative breast magnetic resonance imaging (MRI). However, there are few data with which to evaluate the significance of these proposed etiologies.

Currently, breast MRI is often used in newly diagnosed patients with breast cancer to evaluate the extent of disease and look for additional foci of mammographically occult lesions in the affected breast, and to examine the contralateral breast. However, because MRI is a very sensitive test, the false-positive rate for detected lesions is high, leading to an increased number of image-guided biopsies before definitive surgery. Nonetheless, MRI does detect mammographically occult disease in the ipsilateral breast in 11 to 31%, of patients [5] and in the contralateral breast in 3 to 4% [6]. Although these lesions are usually relatively small when they are detected, surgical treatment planning can be affected. Based on the extent of disease and the location in the breast, patients may undergo wider lumpectomy or mastectomy; however, for the majority of patients in whom no additional lesions are found, management remains unchanged. Whether or not this increased rate of detection of small foci of disease will ultimately lead to improvements in the local recurrence rate and/or mortality rate remains to be determined.

The purpose of this study was to characterize the increased use of preoperative breast MRI at our institution over a 6 year period, and to investigate whether patients who underwent a preoperative breast MRI were more likely to ultimately have a mastectomy than those who did not undergo MRI.

Methods

Using a prospectively maintained database, all newly diagnosed patients with breast cancer who were treated at the Yale New Haven Breast Center from 2004 to 2009 were identified. Patients who did not receive definitive breast surgery during the study period because of distant metastases or neoadjuvant chemotherapy were excluded. Patient and tumor characteristics, imaging and biopsy findings, surgical treatment, and final pathology results were recorded. Yearly mastectomy rates were determined and compared with BCT rates across the 6 year period.

This was a retrospective chart review and was approved by the Yale University IRB as exempt.

Patients who underwent preoperative breast MRI were identified. MRI was performed at the discretion of the treating breast surgeon. Those with additional suspicious lesions were identified, and biopsy results were obtained. Operative, imaging, and pathology reports were reviewed and compared with data in the clinical chart for accuracy.

Statistical analysis

Statistical analysis was performed using SPSS statistical software (SPSS Inc., Chicago, IL, USA). Categorical data were compared with χ2 tests and means of continuous data were compared with t-tests. Multivariable analysis was performed with logistic regression. All significance testing was two-sided.

Results

In total, 1,445 patients with newly diagnosed breast cancer had definitive breast surgery at the Yale New Haven Breast Center from 2004 to 2009. Of this group, 628 patients (43%) underwent diagnostic MRI. Patient and tumor characteristics for the two groups are presented in Table 1. The mean age for those patients who underwent breast MRI was 53 years and the mean age for those who did not was 60 years (P<0.001) There was no significant difference in ethnicity, tumor stage, tumor histology or mean tumor size between the two groups.
Table 1

Patient and tumor characteristics

 

MRI (n = 628)

No MRI (n = 817)

P-value

Age, years

   

  Mean

53

60

<0.001

  <50

43%

26%

<0.001

  >50

56%

73%

<0.001

Ethnicity

   

  Asian

3%

2%

NS

  Black

8%

12%

NS

  Hispanic

6%

4%

NS

  White

78%

79%

NS

  Other/unknown

5%

3%

NS

Stage

   

  0

23%

27%

0.08

  1

39%

39%

NS

  2

29%

22%

NS

 3

7%

8%

NS

 4

2%

3%

NS

Tumor size (cm)

1.6

1.5

NS

Histology

   

  DCIS

24%

26%

NS

  Infiltrating ductal

59%

53%

NS

  Infiltrating lobular

12%

11%

NS

  Other

5%

10%

NS

Abbreviations: DCIS ductal carcinoma in situ, MRI magnetic resonance imaging, NS non-significant.

The use of preoperative MRI increased sharply over the study period, from 6% of newly diagnosed patients with breast cancer in 2004 to 73% in 2009. The rates of lumpectomy and unilateral mastectomy declined slightly over this period, whereas the rate of bilateral mastectomy increased (Figure 1).
Figure 1

Magnetic resonance imaging (MRI) use and definitive surgery over time.

The relationship between the type of breast surgery performed and MRI usage is shown in Table 2. The number of partial mastectomies performed over the study period was 355 (57%) in the group who underwent preoperative MRI and 504 (62%) in the group who did not (P = 0.06). Thus MRI was associated with a non-significant trend toward a lower lumpectomy rate.
Table 2

Surgical treatment for those who had definitive surgery

Type of surgery

MRI (n = 628)

No MRI (n = 817)

P-value

Partialmastectomy

355 (57%)

504 (62%)

0.06

Unilateralmastectomy

147 (23%)

211 (26%)

NS

Bilateralmastectomy

123 (20%)

102 (12%)

<0.005

Abbreviations: MRI magnetic resonance imaging, NS non-significant.

There was no significant difference between the two groups with regard to unilateral mastectomy (23% and 26%, respectively), but the number of bilateral mastectomies performed was significantly higher in the group that underwent preoperative MRI (123 (20%) versus 102 (12%), P<0.005).

Table 3 shows some of the outcomes associated with the use of MRI. Of 628 patients who underwent preoperative breast MRI, 369 (59%) had abnormal results: 29% on the ipsilateral side, 12% on the contralateral side, and 18% in both breasts. In total, 257 patients (41%) underwent one or more biopsies. Most often, targeted ultrasound with image-guided core biopsy was attempted before MRI guided biopsy. Malignant results were documented by biopsy results in the ipsilateral breast in 52 cases (8%), the contralateral breast in 15 (2%), and both in 6 (1%).
Table 3

Surgical treatment according to the results of magnetic resonance imaging (MRI)

MRI results

n

Lumpectomy

Ipsilateral mastectomy

Bilateral mastectomy

No MRI

817

62%

26%

12%

MRI

    

  Normal

259

66%

17%c

16%

  Abnormal

    

  Ipsilateral

182

51%c

34%c

15%

  Contralateral

73

53%

21%

26%c

  Both

114

46%c

23%

31%c

MRI biopsya

    

  None

132

39%c

35%c

26%c

  Benign

184

66%

21%

13%

  Malignant

    

  Ipsilateralb

52

35%c

38%c

27%c

  Contralateral

15

33%c

0c

67%c

  Both

6

0c

0

100%c

aFor those with abnormal MRI.

bIn addition to index lesion.

cP<0.05 compared with the rate for the same surgery with no MRI.

The outcome of the MRI strongly influenced the choice of surgery compared with the group that did not undergo MRI. As might be expected, a diagnosis of a second ipsilateral or contralateral malignancy was associated with a decreased lumpectomy rate and an increase in the rates of unilateral and bilateral mastectomy. However, the group that had an abnormal MRI and did not undergo biopsy also had a lumpectomy rate of only 39%, and the rates of unilateral and bilateral mastectomy were 35% and 26%, respectively. We were not able to determine how many of these women chose mastectomy to avoid another needle biopsy. Although not significant, when compared with the women who did not have an MRI, the women with a normal MRI or a benign biopsy actually had an increased lumpectomy rate (66% and 62%). Thus, some women who were considering mastectomy may have chosen lumpectomy based on the MRI results. This may explain why the use of MRI had a relatively modest effect overall on the lumpectomy rate.

Because young women were more likely to receive an MRI and also more likely to choose bilateral mastectomy, a multivariable logistic regression model was constructed with age, stage, and MRI use. As seen in Table 4, both young age and MRI use were independently associated with an increased rate of bilateral mastectomy.
Table 4

Multivariable logistic regression for bilateral mastectomy

Characteristic

OR (95% CI)

P value

Age

  

  Over 50

Reference

 

  Under 50

3.47 (2.57 to 4.70)

< 0.001

MRI use

  

  No

Reference

 

  Yes

1.38 (1.02 to 1.87)

0.036

Abbreviations: CI confidence interval, MRI magnetic resonance imaging, OR odds ratio.

Discussion

The use of preoperative MRI in patients with newly diagnosed breast cancer is controversial. Proponents of the test are supported by studies showing that breast MRI detects mammographically occult disease in both the ipsilateral and the contralateral breast, has overall sensitivity rates ranging from 73 to 94%, and has a positive predictive value ranging anywhere from 24 to 89% [711]. There is speculation that better preoperative imaging with MRI may lead to decreased numbers of patients with positive margins, and thus lower recurrence rates and ultimately improved overall survival, although to date these data are conflicting [12, 13]. Because of the low recurrence rate after BCT, studies designed to show a difference in these outcome measures would require large numbers to achieve statistical significance and long term follow-up to detect recurrence rates, and may be difficult to perform.

On the other hand, preoperative breast MRI has been criticized for several reasons. These include but are not limited to: delays in surgical management, an unacceptably high false-positive rate, increased costs associated with the test itself and with additional biopsies, heightened patient anxiety, and unnecessary changes in surgical management to avoid additional biopsy and/or the perceived risk of a future recurrence. Although individual studies vary, a recent review by Houssami and Hayes reported that, based on pooled estimates from meta-analyses, preoperative breast MRI led to more extensive surgery in 11.3% of patients, including wider resection or mastectomy, and that 8.1% of all women eligible for BCT were treated with mastectomy because of MRI-only detection of additional disease [14].

Nonetheless, the use of preoperative breast MRI has gained momentum in the surgical community. Although its use varies by geographic region, up to 74% of all breast imaging centers offer the test [15]. Thus, it appears that the selective use of preoperative breast MRI is increasingly being used to guide clinical decision-making for newly diagnosed patients. Our data support this trend. Over the study period, there was an increase in both the percentage of newly diagnosed patients who underwent preoperative MRI and the percentage of patients who underwent biopsy for MRI-detected lesions. Although we may still be on the steep portion of the learning curve with regard to the characterization of suspicious lesions seen on MRI, addressing the low specificity of MRI is certainly an area for which further research is warranted. In addition, whether these additional areas might ever become clinically significant, especially among older patients and patients undergoing post-operative radiation therapy, remains an area of debate.

The observed increase in the utilization of preoperative breast MRI and a concurrent rise in the number of unilateral and bilateral mastectomies performed over the past several years have led researchers to wonder if the two events are related. Several recent studies have reported increasing rates of contralateral prophylactic mastectomy, especially among younger, highly educated patients, and those with a positive family history [4, 1618]. Although this phenomenon does coincide with the adoption of preoperative breast MRI, it is not yet clear whether the relationship is one of cause and effect. In the present study, BCT rates did decrease slightly over the study period in favor of mastectomy, going from 60% in 2004 to 54% in 2009, but the use of preoperative MRI increased much more sharply. Interestingly, the highest BCT rates of any group were among patients with a normal MRI, (66%), even compared with those who did not undergo MRI. Perhaps an MRI scan that does not show any additional suspicious findings can help guide patients who are interested in pursuing BCT.

In a recent editorial, Tuttle asked whether patients with abnormal MRI findings and biopsy on the contralateral side might be more inclined to undergo bilateral mastectomy than those who did not [19]. In our study, we examined this question, and found that this was indeed the case. The greatest difference with regard to definitive surgical management was in the type of mastectomy performed that is, unilateral versus bilateral. In 2004, 15% (n = 20) of patients underwent bilateral mastectomy, but by 2009, 27% of patients (n = 56) underwent bilateral mastectomy. During the same period, the use of preoperative MRI increased from 6% to 73%. Compared with other treatment options, those who underwent bilateral mastectomy were more likely to have had a contralateral biopsy-proven malignancy based on MRI findings. Although abnormal breast MRI findings may have influenced the decision to undergo bilateral mastectomy, it is probable that there are a host of factors that affect the choice of definitive surgery for any given patient. It is likely that physician recommendations, patient age, family history, genetic testing, and reconstruction options all play a role.

Conclusion

In summary, we found a dramatic increase in the use of preoperative breast MRI among newly diagnosed patients with breast cancer over the 6 year period of the study. A preoperative MRI that revealed only the known cancer, or that led to a benign biopsy, was associated with a higher rate of BCT over mastectomy. Thus, although there is a strong relationship between the result of the MRI and the choice of surgery, the overall effect is not always to increase the mastectomy rate.

Declarations

Authors’ Affiliations

(1)
Department of Surgery, Yale University School of Medicine
(2)
Department of Radiology, Yale University School of Medicine
(3)
The Breast Center-Smilow Cancer Hospital at Yale New Haven

References

  1. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002, 347: 1227-1232. 10.1056/NEJMoa020989.View ArticlePubMedGoogle Scholar
  2. Du X, Freeman DH, Syblik DA: What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Res Treat. 2000, 62: 71-79. 10.1023/A:1006414122201.View ArticlePubMedGoogle Scholar
  3. Katipamula R, Degnim AC, Hoskin T: Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009, 27: 4082-4088. 10.1200/JCO.2008.19.4225.PubMed CentralView ArticlePubMedGoogle Scholar
  4. McGuire KP, Santillan A, Kaur P: Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy vs. breast conservation in 5865 patients. Ann Surg Oncol. 2009, 16 (Suppl 1): 24.Google Scholar
  5. Morrow M, Freedman G: A clinical oncology perspective on the use of breast MR. Magn Reson Imaging Clin N Am. 2006, 14: 363-378. 10.1016/j.mric.2006.07.006.View ArticlePubMedGoogle Scholar
  6. Lehman CD, Blume JD, Thickman D: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007, 356: 1295-1303. 10.1056/NEJMoa065447.View ArticlePubMedGoogle Scholar
  7. Orel SG, Schnall MD, LiVolsi VA, Troupin RH: Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology. 1994, 190: 485-493.View ArticlePubMedGoogle Scholar
  8. Weinreb JC, Newstead G: MR imaging of the breast. Radiology. 1995, 196: 593-610.View ArticlePubMedGoogle Scholar
  9. Brem Bluemke DA, Gatsonis CA, Chen MH: Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004, 22: 2735-2742.View ArticleGoogle Scholar
  10. Burstein HJ, Polyak K, Wong JS: Ductal carcinoma in situ of the breast. N Engl J Med. 2004, 350: 1430-1441. 10.1056/NEJMra031301.View ArticlePubMedGoogle Scholar
  11. Orel SG, Mendonca MH, Reynolds C: MR imaging of ductal carcinoma is situ. Radiology. 1997, 202: 413-420.View ArticlePubMedGoogle Scholar
  12. Fischer U, Zachariae O, Baum F: The influence of preoperative MRI of the breast on recurrence rate in patients with breast cancer. Eur Radiol. 2004, 14: 1725-1731.View ArticlePubMedGoogle Scholar
  13. Solin LJ, Orel SG, Wei-Ting H: Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008, 26: 386-391. 10.1200/JCO.2006.09.5448.View ArticlePubMedGoogle Scholar
  14. Houssami N, Ciatto S, Macaskill P: Accuracy and surgical impact of magnetic resonance imagin in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008, 26: 3248-3258. 10.1200/JCO.2007.15.2108.View ArticlePubMedGoogle Scholar
  15. Le-Petross HT: Breast MRI, as a screening tool: the appropriate role. J Natl Compr Canc Netw. 2006, 4: 523-526.PubMedGoogle Scholar
  16. Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM: Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009, 16: 2691-2696. 10.1245/s10434-009-0547-9.View ArticlePubMedGoogle Scholar
  17. McLaughlin CC, Lilquist PP, Edge SB: Surveillance of prophylactic mastectomy: trends in Use from 1995 through 2005. Cancer. 2009, epubGoogle Scholar
  18. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007, 25 (33): 5203-5209. 10.1200/JCO.2007.12.3141.View ArticlePubMedGoogle Scholar
  19. Tuttle TM: Magnetic resonance imaging and contralateral prophylactic mastectomy: the “No Más” effect?. Ann Surg Oncol. 2009, 16: 1461-1462. 10.1245/s10434-009-0427-3.View ArticlePubMedGoogle Scholar

Copyright

© Killelea et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement